Document Detail

In vitro activity of JPC 2067 alone and in combination with sulfamethoxazole against nocardia species.
MedLine Citation:
PMID:  22106219     Owner:  NLM     Status:  MEDLINE    
JPC 2067 is a novel dihydrotriazine dihydrofolate reductase inhibitor that is being developed as an antimalarial therapeutic. We evaluated the in vitro activity of JPC 2067 alone and in combination with sulfamethoxazole (SMX) against a panel of nocardia isolates. The MIC(50)s and MIC(90)s for JPC 2067, SMX, and the combination were 0.125 μg/ml and 4 μg/ml, 16 μg/ml and 32 μg/ml, and 0.03 μg/ml and 2 μg/ml, respectively. JPC 2067 alone and in combination with SMX should be evaluated further to understand its clinical potential.
Swagatam Mookherjee; Carolyn Shoen; Michael Cynamon
Related Documents :
10799839 - Viability and infectivity of two cryptosporidium parvum bovine isolates from different ...
15715229 - Transmission of neospora caninum between wild and domestic animals.
7570849 - The use of isoelectric focusing on polyacrylamide gel for the enzymatic analysis of 'ol...
11475049 - Genetic variation in a host-parasite association: potential for coevolution and frequen...
21645629 - Extracellular phospholipase activity of malassezia strains isolated from individuals wi...
21156559 - Intraspecific variation in heterobasidion annosum for mortality rate on pinus sylvestri...
11518319 - Taxonomic characterization of new alkaliphilic and alkalitolerant methanotrophs from so...
17330799 - Three cases of invasive meningococcal disease caused by a capsule null locus strain cir...
21154759 - Adaptation yields a highly efficient xylose-fermenting zymomonas mobilis strain.
Publication Detail:
Type:  Journal Article     Date:  2011-11-21
Journal Detail:
Title:  Antimicrobial agents and chemotherapy     Volume:  56     ISSN:  1098-6596     ISO Abbreviation:  Antimicrob. Agents Chemother.     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-01-23     Completed Date:  2012-05-25     Revised Date:  2013-06-27    
Medline Journal Info:
Nlm Unique ID:  0315061     Medline TA:  Antimicrob Agents Chemother     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1133-4     Citation Subset:  IM    
Department of Medicine, VAMC, Syracuse, New York, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Bacterial Agents / pharmacology*
Drug Therapy, Combination
Microbial Sensitivity Tests / standards
Nocardia / classification,  drug effects*,  isolation & purification
Nocardia Infections / microbiology*
Sulfamethoxazole / pharmacology*
Tetrahydrofolate Dehydrogenase / drug effects
Triazines / chemistry,  pharmacology*
Reg. No./Substance:
0/Anti-Bacterial Agents; 0/Triazines; 723-46-6/Sulfamethoxazole; EC Dehydrogenase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Phenylethyl butyrate enhances the potency of second-line drugs against clinical isolates of Mycobact...
Next Document:  Virulence factors and TEM-type ?-lactamases produced by two isolates of an epidemic Klebsiella pneum...